DPP-4 inhibitors and type 2 diabetes mellitus in parkinsons disease: a mutual relationship
This framework is intended as a conceptual guide rather than a deterministic regulatory algorithm
To gain further insight, a non-compartmental PK analysis was performed using gPKPDSim 74 , which revealed a 3.8-fold slower clearance rate (CL) and a 2.4-fold longer mean residence time (MRT) of QMP compared with WT albumin (Supplementary Table 4)
Amphetamine-based medications like Adderall, Vyvanse, or Dexedrine, or methylphenidate-based medications like Ritalin or Concerta
If you've already adjusted to your current dose level and you miss one dose, you generally don't have to re-experience the initial side effects when you resume
TRIUMPH-5: type 2 diabetes, active-comparator design